Caspofungin acetate

This classification denotes an antifungal agent with the molecular formula C52H88N10O15.2C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VUW370O5QE, chemically known as pneumocandin b0, 1-((4r,5s)-5-((2-aminoethyl)amino)-n2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-l-ornithine)-5-((3r)-3-hydroxy-l-ornithine)-, diacetate (salt) but more generally known as caspofungin acetate, which bears US NIH Compound Identifier 123623. The base compound, Caspofungin, most often comes in base and acetate forms. European Medicines Agency schedules Caspofungin acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12476MIG. Most nations, for tariff and trade purposes, schedule caspofungin acetate under HS 29419000 and SITC 54139. As of Q4 2014, CASPOFUNGIN ACETATE remains US FDA's Preferred Term for this commodity. Caspofungin acetate bears US NLM identifiers UMLS ID C0935942 and NCI Concept Code C1724. SMILES: CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4CCC(CC4)O)O)O)[C@@H](CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O.